Lecidella carpathica
| Lecidella carpathica | |
|---|---|
| |
| Scientific classification | |
| Kingdom: | Fungi |
| Division: | Ascomycota |
| Class: | Lecanoromycetes |
| Order: | Lecanorales |
| Family: | Lecanoraceae |
| Genus: | Lecidella |
| Species: | L. carpathica |
| Binomial name | |
| Lecidella carpathica Körb. (1861) | |
| Synonyms[1] | |
| List
| |
Lecidella carpathica is a species of crustose lichen in the family Lecanoraceae.[2] It was formally described as a new species in 1861 by the German lichenologist Gustav Wilhelm Körber.[3]
Three secondary metabolites that occur in this species, hopane-6α,22-diol, brialmontin, and atraric acid, inhibit the enzyme protein tyrosine phosphatase 1B. This enzyme is a therapeutic target for diabetes treatments and plays a major role in negative regulation of the insulin signaling pathway.[4]
References
- ^ "Synonymy. Current Name: Lecidella carpathica Körb., Parerga lichenol. (Breslau) 3: 212 (1861) [1865]". Species Fungorum. Retrieved 31 March 2025.
- ^ "Lecidella carpathica Körb". Catalogue of Life. Species 2000: Leiden, the Netherlands. Retrieved 31 March 2025.
- ^ Körber, G.W. (1861). Parerga lichenologica. Ergänzungen zum Systema lichenum Germaniae (in German). Vol. 3. pp. 193–288 [212].
- ^ Seo, Changon; HanYim, Joung; Kum Lee, Hong; Oh, Hyuncheol (2011). "PTP1B inhibitory secondary metabolites from the Antarctic lichen Lecidella carpathica". Mycology. 2 (1): 18–23. doi:10.1080/21501203.2011.554906.
.jpg)